ALB-185357

• CAT Number: I021721
• CAS Number: 1841125-91-4
• Molecular Formula: C16H14N4O4
• Molecular Weight: 326.31
• Purity: 98%
• Synonyms: ALB-185357; ALB 185357; ALB185357; Metavert
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-hydroxy-4-[5-(4-methoxyanilino)-1,3,4-oxadiazol-2-yl]benzamide
• InChI: InChI=1S/C16H14N4O4/c1-23-13-8-6-12(7-9-13)17-16-19-18-15(24-16)11-4-2-10(3-5-11)14(21)20-22/h2-9,22H,1H3,(H,17,19)(H,20,21)
• InChIKey: TWABKXHHSQCZPI-UHFFFAOYSA-N
• SMILES: COC1=CC=C(C=C1)NC2=NN=C(O2)C3=CC=C(C=C3)C(=O)NO

ALB-185357（Cat No.:I021721）is an investigational small molecule compound being studied for its potential therapeutic applications in cancer treatment. It is a selective inhibitor of certain kinases involved in cellular signaling pathways that regulate cell proliferation, survival, and apoptosis. By targeting these kinases, ALB-185357 aims to disrupt tumor growth and enhance the effectiveness of existing cancer therapies. Preclinical studies have shown promise in inhibiting the growth of various cancer cell lines, including those resistant to conventional treatments.